These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 7581101

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B, Majolino I, Dreger P, Scimè R, Santoro A, Vasta S, Suttorp M, Haferlach T, Schmitz N.
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [Abstract] [Full Text] [Related]

  • 3. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, Rolstad B.
    Transplantation; 2008 Jan 15; 85(1):102-11. PubMed ID: 18192919
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation.
    Or R, Hadar E, Bitan M, Resnick IB, Aker M, Ackerstein A, Samuel S, Tsirigotis P, Gesundheit B, Slavin S, Shapira MY.
    Biol Blood Marrow Transplant; 2006 Dec 15; 12(12):1295-301. PubMed ID: 17162211
    [Abstract] [Full Text] [Related]

  • 5. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
    Shiobara S, Nakao S, Ueda M, Yamazaki H, Takahashi S, Asano S, Yabe H, Kato S, Imoto S, Maruta A, Yoshida T, Gondo H, Morishima Y, Kodera Y.
    Bone Marrow Transplant; 2000 Oct 15; 26(7):769-74. PubMed ID: 11042659
    [Abstract] [Full Text] [Related]

  • 6. Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT.
    Szer J, Grigg AP, Phillips GL, Sheridan WP.
    Bone Marrow Transplant; 1993 Feb 15; 11(2):109-11. PubMed ID: 8435660
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R.
    Exp Hematol; 1995 Dec 15; 23(14):1553-62. PubMed ID: 8542946
    [Abstract] [Full Text] [Related]

  • 8. Donor leukocyte infusions for treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation.
    Forés R, Díez-Martin JL, Briz M, Cabrera JR, Sanjuán I, Regidor C, Garcia-Talavera J, Fernandez MN.
    Bone Marrow Transplant; 1996 Mar 15; 17(3):439-41. PubMed ID: 8704703
    [Abstract] [Full Text] [Related]

  • 9. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD, Becker EE, Truitt RL.
    Biol Blood Marrow Transplant; 1999 Mar 15; 5(3):123-32. PubMed ID: 10392958
    [Abstract] [Full Text] [Related]

  • 10. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA.
    Dan Med Bull; 2002 May 15; 49(2):89-108. PubMed ID: 12064093
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Ball E, Cook D, Andresen S, Kuczkowski E, Bolwell B.
    Bone Marrow Transplant; 2005 Feb 15; 35(3):247-52. PubMed ID: 15580282
    [Abstract] [Full Text] [Related]

  • 13. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP.
    Biol Blood Marrow Transplant; 2009 Feb 15; 15(2):257-65. PubMed ID: 19167686
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].
    Sanz Rodríguez C, Steegmann JL, Granda A, de la Cámara R, Figuera A, Arranz R, Gómez-García de Soria V, Alegre A, Fernández-Rañada JM.
    Sangre (Barc); 1999 Dec 15; 44(6):456-63. PubMed ID: 10822760
    [Abstract] [Full Text] [Related]

  • 15. Long-term molecular remission induced by donor lymphocyte infusions for recurrent acute myeloblastic leukemia after allogeneic bone marrow transplantation.
    Imoto S, Murayama T, Gomyo H, Mizuno I, Sugimoto T, Nakagawa T, Koizumi T.
    Bone Marrow Transplant; 2000 Oct 15; 26(7):809-10. PubMed ID: 11042667
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation.
    Mehta J, Powles R, Singhal S, Tait D, Swansbury J, Treleaven J.
    Bone Marrow Transplant; 1995 Jul 15; 16(1):133-7. PubMed ID: 7581113
    [Abstract] [Full Text] [Related]

  • 18. Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse.
    Choi SJ, Lee JH, Lee JH, Kim S, Seol M, Lee YS, Lee JS, Kim WK, Chi HS, Lee KH.
    Leukemia; 2004 Nov 15; 18(11):1789-97. PubMed ID: 15385924
    [Abstract] [Full Text] [Related]

  • 19. Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.
    Porter DL, Roth MS, Lee SJ, McGarigle C, Ferrara JL, Antin JH.
    Bone Marrow Transplant; 1996 Nov 15; 18(5):975-80. PubMed ID: 8932854
    [Abstract] [Full Text] [Related]

  • 20. Allogeneic bone marrow transplantation from partially mismatched related donors as therapy for primary induction failure acute myeloid leukemia.
    Chiang KY, Van Rhee F, Godder K, Bridges K, Adams S, Mehta J, Henslee-Downey PJ.
    Bone Marrow Transplant; 2001 Mar 15; 27(5):507-10. PubMed ID: 11313684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.